🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent short commentary led by Dr Max Julvé and Dr Mark Lythgoe. First-line trials now in progress! The Royal Marsden NHS Foundation Trust NIHR Royal Marsden BRC with @ICRLondon and CRF The Royal Marsden Cancer Charity Iovance Biotherapeutics

Congratulations to Professors Christopher Denton @IIT_UCL, Alison Rodger UCL Global Health, @Mayor_lab @UCLBiosciences & @SQuezadd @UCLCancer on their election as Fellows to @AcMedSci in recognition of their outstanding contributions to biomedical research ucl.ac.uk/news/2024/may/…

Absolutely honoured to be elected Fellow of the Academy of Medical Sciences together with amazing ⁦UCL⁩ colleagues!! Thanks to ⁦⁦UCL Cancer Institute⁩ ⁦Cancer Research UK⁩ and my amazing team ⁦Quezada Lab⁩ ucl.ac.uk/news/2024/may/…

En route to #ASCO24 for the first time! Come and check out our poster on Saturday at board #355 1:30pm Hall A meetings.asco.org/abstracts-pres…

IOV-COM-202 cohort 1A - Efficacy of lifileucel, an autologous TIL cell therapy & pembro in pts w/ ICI-naive unresectable or metastatic melanoma - 22 pts included. After median FUP of 17.2 mos, conformed ORR was 63.6% and median DOR not reached. #Skincancer #ASCO24

Next up IOV-COM-202 with front line data for #TIL + pembro in front line melanoma treatment. This is the lead up to the ongoing phase 3 #TILVANCE trial. #ASCO24 #Melanoma OncoAlert

A pleasure presenting our novel granulocyte ratio (NEBR) melanoma data at #ASCO24. Lots of interesting discussion! Dr Sophia Wong Andrew Furness The Royal Marsden NHS Foundation Trust

.⁦Sunita_Puri⁩ suggests that, if we are to heal ourselves as oncologists, we need to separate the endpoint of cure from the delivery of meaningful care What if sitting at bedside with a dying patient mattered as much to our self-worth as an exceptional response? #asco24

So happy to be present to see this historic moment ASCO #ASCO24 #melanoma #melsm 📈 🏅 Congratulations Christian Blank and the entire #NADINA team❗️

Join sarcoma oncologist Dr. Sandra D’Angelo (Sandra P D'Angelo, MD) as she shares analysis of the pivotal IGNYTE-ESO trial of lete-cel in patients with synovial sarcoma or myxoid/round cell #liposarcoma at ASCO. #ASCO24 Learn more: bit.ly/4c1Ed3f 📅: 6/3 at 11:30am (CT)

Our own Prof. Roda Amaria ⁦MD Anderson Cancer Center⁩ presenting first results of engineered T cell therapy OBX-115, eliminates need for IL-2, inducible & regulatable construct with oral acetazolamide. Impressive safety & early efficacy data ORR 44% , 22% CR ICI refractory disease

Favorite slide of #ASCO24. Let’s be impatient for our patients.

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…

Congratulations Dr Juliet Carmichael from the de Bono team The ICR The Royal Marsden NHS Foundation Trust providing an overview of therapeutic strategies utilising B7-H3 (localisation over function) in advanced prostate cancer.

We're delighted to lead a new project with @RoyalMarsdenNHS to study responses to cancer immunotherapy. The platform has received £20m+ in public and industry investment and will involve thousands of people from across the UK receiving immunotherapy. 🔗 crick.ac.uk/news-and-repor…

Delighted to share our new paper reviewing toxicity management strategies for solid tumour cell therapy in ESMO IOTECH . A great team effort from Dr Sophia Wong Jon Lim, MRCP PhD Andrew Furness ! sciencedirect.com/science/articl…

Been sharing this review on solid tumour cellular therapy toxicity management since #ESMO24 and am delighted to share full proofs are now out in ESMO IOTECH sciencedirect.com/science/articl… Could not have done this without the awesome team Dr Max Julvé Jon Lim, MRCP PhD Andrew Furness

Toxicity management strategies for solid tumour cell therapy - Dr Max Julvé oncodaily.com/url/218317 ESMO IOTECH Dr Sophia Wong Jon Lim, MRCP PhD Andrew Furness #Cancer #SolidTumors #ImmuneOnc #IO #ImmunoOncology #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

First day of Lee Lab (further name tbc) !!! Exciting and a bit scary! Any tips and advice very gratefully received!! 🎉🎉

The art of TIL therapy: Perspective from Society for Immunotherapy of Cancer 👉Free access jitc.bmj.com/content/13/1/e… at Journal for ImmunoTherapy of Cancer